GLUCOFEX
Natural health product licensed in Canada
- Other names
- DIAB-M 21, DIAB-V Rx, GLUCOFEX 1000, NUTRADIAB
- Licence holder
- Nutra-V Inc.
- NPN or DIN-HM
- 80061198
- Status
- Active licence
- Licence date
- 25 May 2015
- Revision date
- 29 June 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Chrome: up to 150 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Chrome Source : Picolinate de chrome | 37.5 mcg | 150 µg |
| Fraxinus excelsior Source : Fruit Extraction ratio : 7:1 Dry plant equivalent : 1,750 mg Potency : 6.8 % Nuzhenide | 250 mg | Not calculated |
| Fraxinus excelsior Source : Graine(s) Extraction ratio : 7:1 Dry plant equivalent : 1,750 mg Potency : 6.8 % Nuzhenide | 250 mg | Not calculated |
| Fraxinus excelsior Source : Fruit Potency : 5.8 % GI3 | Not specified | Not calculated |
| Fraxinus excelsior Source : Graine(s) Potency : 5.8 % GI3 | Not specified | Not calculated |
| bêta-glucane Source : Bêta-glucane | 150 mg | Not calculated |
| bêta-glucane Source : Avena sativa - fibre (graine) | 150 mg | Not calculated |
| Acide DL-alpha lipoÏque Source : Acide DL-alpha-lipoÏque | 75 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Eau, Cellulose microcristalline, cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides antioxidants for the maintenance of good health. Provides support for healthy glucose metabolism. Helps the body to metabolize carbohydrates. Helps the body to metabolize fats.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80061198
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging